← FDA Drug Approvals (Drugs@FDA)
BUDESONIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL · Approved 2023-04-12
Drug application
- FDA Application #
ANDA215328- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BUDESONIDE
- Generic name
- BUDESONIDE
- Active ingredients
- BUDESONIDE
- Dosage form
- AEROSOL, FOAM
- Route
- RECTAL
- Marketing status
- Prescription
- Sponsor
- PADAGIS ISRAEL
- Manufacturer
- Padagis Israel Pharmaceuticals Ltd
- First approval
- 2023-04-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown